An Analyst Upgraded TherapeuticsMD Stock from “Perform” to “Outperform” Today
On Tuesday, after Jay Olson, an analyst at Oppenheimer, upgraded TherapeuticsMD (NYSEMKT:$TXMD) stock from “Perform” to “Outperform”, shares of TXMD increased 18%. Additionally, the analyst gave TherapeuticsMD shares a $10 price target, which means that …
This Is Why Ocular Therapeutix Inc.’s Stock Hit the Ceiling Today – July 11, 2017
A few days ago, shares of biopharmaceutical startup Ocular Therapeutix (NASDAQ:$OCUL) were plummeting — but on July 11, the company’s shares shot up by 26%. This is largely due to the fact that Ocular Therapeutix …
Arena Pharmaceutical Inc.’s Shares Sees New Heights After Positive Results of Drug Study
Shares of Arena Pharmaceuticals Inc. (NASDAQ:$ARNA), a company that works on developing and commercializing a number of biopharmaceutical products, went up by 35% late in the day of July 10, 2017. The rise can largely …
This is Why Shares of Ocular Therapeutix Inc. Spiraled Today – July 7, 2017
As of around 4:50 PM EDT on July 7, 2017, Ocular Therapeutix Inc.’s (NASDAQ:$OCUL) stocks have fallen by 25.05% to $7.12 from its $9.05 opening this morning. The dramatic fall occurred after Adam Feuerstein at …
This is Why BeiGene Ltd.’s Shares Rose Significantly on July 6, 2017
At one point on the morning of July 7, 2017, biopharma company BeiGene Ltd.’s shares (NASDAQ:$BGNE) went up as high as 31%. The rise in prices came shortly after the company announced a partnership with …
Celsion Corp’s Stock Increased Almost 25% Today
On Wednesday, July 5, in a morning trading session, shares of Celsion Corp. (NASDAQ:$CLSN) increased almost 25% to $2.53. This jump occurred after the New Jersey-based firm disclosed the completion of the Ovation study, a …
A British Biotech Company is Close to a Breakthrough Blood Test for Diagnosing Ovarian Cancer
On Monday, U.K-based biotech company Angle plc (OTCQX:$ANPCY) disclosed the trial results of a possible breakthrough blood test for diagnosing ovarian cancer.
Essentially, Angle’s blood test could allow for a quicker diagnosis and …
Should You Invest in Conatus Pharmaceuticals Inc.?
Conatus Pharmaceuticals Inc. (NASDAQ:$CNAT), a biotech-pharmaceutical company focused on developing drugs to treat liver disease, has been seeing quite a rise in its stocks recently. This can be largely due to the company’s announcement a …
Mylan Faces More Criticism for Excessive Pay Package to Its Top Executives
Although it had just recently faced a great scandal for continuously raising the prices of EpiPens and have been performing quite poorly on the stock market, pharmaceutical company Mylan (NASDAQ:$MYL) just paid its chairman and …
Congress Announces New Bill to End Federal Prohibition of Medical Cannabis
On June 15, 2017, congress took the first step towards lessening its attitude on medical cannabis.
Senators Corey Booker, Kirsten Gillibrand, and Rand Paul disclosed a new bill which will end the federal …